The risk of upper gastrointestinal bleeding associated with concomitant proton pump inhibitor administration during dual antiplatelet therapy with aspirin and prasugrel: a retrospective single-center study
Abstract Objective Dual‐antiplatelet therapy (DAPT) and proton pump inhibitor (PPI) are frequently prescribed after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) placement. However, studies that evaluate the optimal PPI when used as primary prevention in patients without a...
Saved in:
Main Authors: | Yutaro Ide (Author), Go Morikawa (Author), Kyohei Yoshida (Author), Yuki Takano (Author), Ken Kubota (Author), Katsuko Okazawa (Author), Takeo Yasu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
by: Xiaofeng Luo, et al.
Published: (2023) -
Clinical Outcomes of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
by: Hongzhou Guo, et al.
Published: (2021) -
Antiplatelet agents and proton pump inhibitors – personalizing treatment
by: Eugene Lin, et al.
Published: (2010) -
In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
by: Muhammad Naufal Hibatullah, et al.
Published: (2024) -
Evaluation of Vitamin B12 Monitoring in Patients on Concomitant Metformin and Proton Pump Inhibitors
by: Logan Chappell, et al.
Published: (2020)